Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

NCT00224809 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Heart Diseases
Coronary Disease

Interventions

DRUG: Angiotensin-Converting Enzyme Inhibitors
PROCEDURE: Coronary Artery Bypass Graft
DRUG: Angiotensin Receptor Blockers
DRUG: Spironolactone
DRUG: Aspirin
DRUG: Clopidogrel
PROCEDURE: Surgical Ventricular Restoration

Sponsor

Baylor Research Institute

Collaborators

[object Object]